Trial Profile
Opioid Induced Hyperalgesia: possible to avoid by gradual reduction compared to acute withdrawal from remifentanil?
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Oct 2021
Price :
$35
*
At a glance
- Drugs Remifentanil (Primary)
- Indications Hyperalgesia
- Focus Pharmacodynamics
- 05 Oct 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health, NCT01702389)
- 20 Mar 2012 New trial record